Ryo Takeuchi
Company: Excision BioTherapeutics Inc.
Job title: Senior Director, Genome Editing
Seminars:
9.30 Leveraging EBT-101 Preclinical & Early Clinical Development for New In Vivo Multiplex Editing Programs 9:30 am
day: Day One AM